The establishment of self-renewing hepatoblast-like cells (HBCs) from human pluripotent stem cells (PSCs) would realize a stable supply of hepatocyte-like cells for medical applications. However, the functional characterization of human PSC-derived HBCs was not enough. To purify and expand human PSC-derived HBCs, human PSC-derived HBCs were cultured on dishes coated with various types of human recombinant laminins (LN). Human PSC-derived HBCs attached to human laminin-111 (LN111)-coated dish via integrin alpha 6 and beta 1 and were purified and expanded by culturing on the LN111-coated dish, but not by culturing on dishes coated with other laminin isoforms. By culturing on the LN111-coated dish, human PSC-derived HBCs were maintained for more than 3 months and had the ability to differentiate into both hepatocyte-like cells and cholangiocyte-like cells. These expandable human PSC-derived HBCs would be manageable tools for drug screening, experimental platforms to elucidate mechanisms of hepatoblasts, and cell sources for hepatic regenerative therapy.
INTRODUCTION
Human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) have the ability to self-replicate and to differentiate into all types of body cells including hepatoblasts and hepatocytes. Although cryopreserved primary human hepatocytes are useful in drug screening and liver cell transplantation, they rapidly lose their functions (such as drug metabolism capacity) and hardly proliferate in in vitro culture systems. On the other hand, human hepatic stem cells from fetal and postnatal human liver are able to self-replicate and able to differentiate into hepatocytes (Schmelzer et al., 2007; Zhang et al., 2008) . However, the source of human hepatic stem cells is limited, and these cells are not available commercially. Therefore, the human pluripotent stem cell (hPSC)derived hepatoblast-like cells (HBCs), which have potential to differentiate into the hepatocyte-like cells, would be an attractive cell source to provide abundant hepatocyte-like cells for drug screening and liver cell transplantation.
Because expandable and multipotent hepatoblasts or hepatic stem cells are of value, suitable culture conditions for the maintenance of hepatoblasts or hepatic stem cells obtained from fetal or adult mouse liver were developed (Kamiya et al., 2009; Tanimizu et al., 2004) . Soluble factors, such as hepatocyte growth factor (HGF) and epidermal growth factor (EGF), are known to support the proliferation of mouse hepatic stem cells and hepatoblast (Kamiya et al., 2009; Tanimizu et al., 2004) . Extracellular matrix (ECM) also affects the maintenance of hepatoblasts or hepatic stem cells. Laminin can maintain the character of mouse hepatoblasts (Dlk1-positive cells) (Tanimizu et al., 2004) . However, the methodology for maintaining HBCs differentiated from hPSCs has not been well investigated. Zhao et al. (2009) have reported that hESC-derived hepatoblastlike cells (sorted N-cadherin-positive cells were used) could be maintained on STO feeder cells. Although a culture system using STO feeder cells for the maintenance of hepatoblast-like cells might be useful, there are two problems. The first problem is that N-cadherin is not a specific marker for human hepatoblasts. N-cadherin is also expressed in hESCderived mesendoderm cells and definitive endoderm (DE) cells (Sumi et al., 2008) . The second problem is that residual undifferentiated cells could be maintained on STO feeder cells. Therefore, their culture condition cannot rule out the possibility of the proliferation of residual undifferentiated cells. Because it is known that hPSC-derived cells have the potential to form teratomas in the host, the production of safer hepatocyte-like cells or hepatoblast-like cells has been required. Therefore, we decided to purify hPSC-derived HBCs, which can differentiate into mature hepatocyte-like cells, and then expand these cells.
In this study, we attempt to determine a suitable culture condition for the extensive expansion of HBCs derived from hPSCs. We found that the HBCs derived from hPSCs can be maintained and proliferated on human laminin-111 (LN111)-coated dishes. To demonstrate that expandable, multipotent, and safe (i.e., devoid of residual undifferentiated cells) hPSC-derived HBCs could be maintained under our culture condition, the hPSC-derived HBCs were used for hepatic and biliary differentiation, colony assay, and transplantation into immunodeficient mice.
RESULTS
Human PSC-Derived Hepatoblast-like Cells Could Adhere onto Human LN111 via Integrin a6 and b1 The HBCs were generated from hPSCs (hESCs and hiPSCs) as described in Figure 1A (details of the characterization of hPSC-derived HBCs are described in Figure 3 ). Definitive endoderm differentiation of hPSCs was promoted by stage-specific transient transduction of FOXA2 in addition to the treatment with appropriate soluble factors (such as Activin A). Overexpression of FOXA2 is not necessary for establishing the hPSC-derived HBCs, but it is helpful for efficient generation of the hPSC-derived HBCs. On day 9, these hESC-derived populations contained two cell populations with distinct morphology ( Figure 1B ). One population resembled human hepatic stem cells that were isolated from human fetal liver (shown in red) (Schmelzer et al., 2007) , whereas the other population resembled definitive endoderm cells (shown in green) (Hay et al., 2008) . The population that resembled human hepatic stem cells was alpha-1-fetoprotein (AFP) positive, whereas the other population was AFP negative ( Figure 1C , left). On day 9, the percentage of AFP-positive cells was approximately 80% ( Figure 1C , right). To characterize these two cell populations (hESC-derived HBC and non-HBC [NHBC] populations), the colonies were manually isolated by using a pipette, and then the gene expression analysis was performed. The gene expression levels of AFP, CD133, EpCAM, CK8, and CK18 in the hESC-derived HBCs were higher than those in the bulk population containing both hESC-derived HBCs and NHBCs (CD133, EpCAM, CK8, and CK18 were named as pan-hepatoblast markers and are known to be strongly expressed in both human hepatic stem cells and hepatoblasts [Schmelzer et al., 2007; Zhang et al., 2008] ) ( Figure 1D ). On the other hand, the gene expressions of AFP, CD133, EpCAM, CK8, and CK18 in the hESC-derived NHBCs were hardly detected. The gene expression levels of DE, mesendoderm, and pluripotent markers in the hESC-derived NHBCs were higher than those in the hESC-derived HBCs, indicating that the hESC-derived NHBCs could remain in a more undifferentiated state than the hESC-derived HBCs (Figures S1A-S1C available online). These results suggest that hepatoblast-like cells could be differentiated from hPSCs.
To purify the hESC-derived HBCs, these cells were plated onto dishes coated with various laminins. There are 15 different laminin isoforms in human tissues. Although laminin is known to be useful to sustain mouse hepatoblasts (Tanimizu et al., 2004) , it remains unknown which human laminin isoform has the potential to purify and expand the HBCs. To identify a human laminin isoform that would be useful for purifying hESC-HBCs, the hESC-HBCs and -NHBCs were plated onto dishes coated with various types of commercially available human laminins ( Figure 1E ). The hESC-derived HBCs could more efficiently adhere onto the human LN111-coated dish compared with hESC-derived NHBCs or unseparated populations (containing both HBCs and NBCs). These data suggest that a hESC-derived HBC population can be purified from the unseparated populations by culturing on human LN111coated dishes. Because integrins are known to be important molecules for cell adhesion to the ECM including laminins, we expected that certain types of integrins would allow selective adhesion of the hESC-derived HBCs to human LN111-coated dish. The gene expression levels of various integrins were examined ( Figure 1F ). Among the integrin a subunits, the gene expression level of integrin a6 in the hESC-derived HBCs was significantly higher than that in the hESC-derived NHBCs. In contrast, among the integrin b subunits, the gene expression level of integrin b1 was higher than those of integrin b2 and b3 in all cell populations. The hESC-derived HBCs, but not NHBCs, expressed both integrin a6 and b1 ( Figure S1D ). Almost all adhesion of the hESC-derived HBCs to a human LN111-coated dish was inhibited by both function-blocking antibodies to integrin a6 and b1 ( Figure 1G ). These results indicated that the hESC-derived HBCs could attach to a human LN111coated dish via integrin a6 and b1.
The hPSC-Derived HBCs Could Be Proliferated and Maintained on a Human LN111-Coated Dish
To obtain the purified hESC-derived HBC population, the hESC-derived cells (day 9) were plated onto a human LN111-coated dish, and then unattached cells were removed at 15 min after plating ( Figure 2A ). Among various laminins, only human LN111 could proliferate ( Figure 2B ) and purify ( Figure 2C ) the AFP-positive population in the presence of HGF and EGF. During culture on the human LN111-coated dish, the morphology of the hESC-derived HBCs gradually changed into that of human hepatoblasts ( Figure S1E ) (Schmelzer et al., 2007) . Therefore, the characteristics of hESC-derived HBCs might be changed by culturing on a human LN111-coated dish (details of the characterization of the hESC-derived HBCs are described in Figure 3 ). After culturing on a human LN111-coated (C) The hESC-derived cells (day 9) were subjected to immunostaining with anti-AFP (red) antibodies. The percentage of AFP-positive cells was examined on day 0 or 9 by using FACS analysis. Data represent the mean ± SD from ten independent experiments. Cells on ''day 0'' and ''day 9'' were compared using Student's t test (p < 0.01). (D) On day 9, the hESC-derived HBCs and NHBCs were manually picked, and the gene expression levels of AFP and pan-hepatoblast markers (CD133, EpCAM, CK8, and CK18) were measured by real-time RT-PCR. The gene expression levels of AFP and pan-hepatoblast markers in the hESC-derived cells (day 9; bulk) were taken as 1.0. Data represent the mean ± SD from four independent experiments. The gene expression levels in the HBCs were significantly different among the three groups (bulk, HBCs, and NHBCs) based on analysis with one-way ANOVA followed by Bonferroni post hoc tests (p < 0.05).
(legend continued on next page)
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Self-Renewing Human ESC/iPSC-Derived HBCs dish for a week, almost all of the cells were still AFP positive (Figures 2C and 2D) . To characterize the cells cultured on various types of human laminins for 7 days, the gene expression levels of AFP and pan-hepatoblast (CD133, CK8, CK18, and EpCAM) markers were examined on day 16 ( Figure 2E ). The gene expression levels of AFP and panhepatoblast markers in the hESC-derived HBCs P1 (HBCs passaged once) did not change as compared with those of the hESC-derived HBCs (day 9; HBC P0) (the definitions of HBC P0, P1, P10, and clone in the present study are shown in Figure S3 ). The gene expression levels of mature hepatocyte and cholangiocyte markers in the hESC-derived HBC P1 did not change as compared with those of the hESC-derived HBC P0 (day 9) ( Figure S1F ). These results suggest that the characteristics of the hESC-derived HBC P1 are similar to those of the hESC-derived HBC P0, although their morphologies are quite different from each other. Interestingly, the gene expression levels of mature cholangiocyte markers in the cells cultured on human LN411-or 511coated dishes were upregulated as compared with those of the hESC-derived HBC P0 (day 9) ( Figure S1F ), suggesting that human LN411 and 511 might promote biliary differentiation. Importantly, both hESC-derived HBCs and hiPSCderived HBCs could extensively proliferate on a human LN111-coated dish for more than 15 passages ( Figure 2F ) in the presence of HGF and EGF. Doubling times of hESC (H9)-derived HBCs and hiPSC (Dotcom)-derived HBCs were approximately 78 and 67 hr, respectively. Almost all of the populations cultured on a human LN111-coated dish were AFP positive ( Figure 2G ). Taken together, these results suggested that the hPSC-derived HBCs would proliferate and be maintained on a human LN111-coated dish.
Characterization of the hESC-Derived HBCs
To characterize the hESC-derived HBCs, the gene expression profiles in the hESC-derived purified HBCs (HBC P0), short-term cultured HBCs (HBCs passaged once [HBC P1]), and long-term cultured HBC (HBCs passaged ten times [HBC P10]) were examined. The hESC-derived HBCs were AFP positive ( Figure 3A ). Although the hESC-derived HBC P0 were negative for ALB, CK7, and CK19, the hESC-derived HBC P1 and P10 were positive for these genes ( Figure 3A ). Both integrin a6 and b1 (receptors of LN111) were strongly expressed in the hESC-derived HBC P0, P1, and P10 ( Figure 3B ). The gene expression levels of human hepatic stem cell markers (N-CAM and Claudin 3 [Schmelzer et al., 2007] ; these are not expressed in human hepatoblasts) in the hESC-derived HBC P0 were higher than those of the hESC-derived HBC P1 and P10 (Figure 3C ). However, the gene expression level of CK19 in the hESC-derived HBC P0 was lower than that of the hESC-derived HBC P1 and P10. The gene expression levels of pan-hepatoblast markers in the hESC-derived HBC P0 were similar to those of the hESC-derived HBC P1 and P10 ( Figure 3D ). The gene expression levels of human hepatoblast markers (ALB, CYP3A7, and I-CAM (Schmelzer et al., 2007) , none of which were expressed in human hepatic stem cells) in the hESC-derived HBC P1 and P10 were higher than those of the hESC-derived HBC P0 (Figure 3E) . However, the AFP expression level in the hESCderived HBC P0 was similar to that of the hESC-derived HBC P1 and P10. Because the gene expression levels of mature hepatocyte and cholangiocyte markers in the hESC-derived HBC P1 and P10 were not increased as compared with those in the hESC-derived HBC P0 (Figure 3F) , the hESC-derived HBC P1 and P10 were not segregated into either of the hepatic and biliary lineages. We also examined the gene expression levels of hepatoblast markers, which have been reported only in mice and not in humans ( Figure 3G ). The characteristics of the hPSCderived HBCs are summarized in Figure S3 . In addition, hESC-derived HBC P0 and HBC P10 showed normal karyotypes ( Figure S2A ). Therefore, the genetic stability of the HBCs was confirmed throughout the maintenance period. Taken together, these results suggest that the hESC-derived HBC P0 resemble human hepatic stem cells and the hESCderived HBC P1 and P10 resemble human hepatoblasts, although some gene expression patterns in the hESCderived HBCs differ from those in human hepatic stem cells and human hepatoblasts, respectively.
(E) The hESC-derived cells (day 9; bulk), HBCs, and NHBCs were plated onto human LN111-, 211-, 411-, or 511-coated dishes, and the attached cells were counted at 60 min after plating. The cell number that was initially plated was taken as 1.0. Data represent the mean ± SD from four independent experiments. The number of attached HBCs on LN111-coated dishes were significantly different among three groups (bulk, HBCs, and NHBCs) based on analysis with one-way ANOVA followed by Bonferroni post hoc tests (p < 0.05).
(F) The gene expression levels of the indicated integrins were measured in the hESC-derived cells (day 9; bulk), HBCs, and NHBCs by realtime RT-PCR. Data represent the mean ± SD from four independent experiments. The gene expression levels of integrin a3 and a6 in the HBCs were significantly different among three groups (bulk, HBCs, and NHBCs) based on analysis with one-way ANOVA followed by Bonferroni post hoc tests (p < 0.05).
(G) The adhesion of the hESC-derived HBCs to human LN111-, 211-, 411-, or 511-coated dishes was examined by using the indicated integrin antibodies. IgG antibodies were used as a control for uninhibited cell adhesion. The number of attached cells was estimated at 60 min after plating. The cell number in the control IgG-treated group was taken as 1.0. Data represent the mean ± SD from three independent experiments. ''Control IgG'' and ''anti-integrin a6 or integrin b1'' were compared using Student's t test. *p < 0.05; ***p < 0.001. See also Figure S1 and Tables S2-S5 . (B) The hESC (H9)-derived cells (day 9) were plated onto a human LN111, 211, 411, or 511-coated dish, and then the cell number were counted on days 10, 12, 14, and 16. The cell number on day 10 was taken as 1.0. Data represent the mean ± SD from three independent experiments. ''LN111'' was significantly different among four groups (LN111, 211, 411, and 511) on day 14 and 16 based on analysis with one-way ANOVA followed by Bonferroni post hoc tests (p < 0.05).
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Self-Renewing Human ESC/iPSC-Derived HBCs
In order to examine whether the hESC-derived HBC P0 have the potential to proliferate clonally on various types of human laminins, single HBCs were plated on separate wells of a human LN111-coated 96-well plate at a low density (one cell per one well) (Table S1 ). Single cells that attached to the human LN111-coated dish were AFP positive and HNF4a positive ( Figure S2B ). At 7 days after plating, the hESC-derived HBC colonies (albumin [ALB]and cytokeratin 7 [CK7] double positive) (a representative colony is shown in Figure S2C ) were efficiently generated from the hESC-derived HBC P0 on a LN111-coated dish. Taken together, these results showed that the hESCderived HBCs could be generated from both the hESCderived HBC P0 population and the single hESC-derived HBC P0.
The hPSC-Derived HBCs Could Differentiate into Both Hepatic and Biliary Lineages In Vitro
To examine whether the hESC-derived HBCs have the potential to differentiate into both hepatic and biliary lineages, first, these cells were differentiated into hepatocytelike cells as described in Figure 4A . After 2 weeks of hepatic differentiation, almost all of the cells were polygonal in shape ( Figure 4B ) and were CYP3A4, aAT, and ALB positive ( Figure 4C ). The gene expression levels of mature hepatocyte markers in the HBC P0-, HBC P10-, or HBC clonederived hepatocyte-like cells were higher than those in the cells that had not undergone hepatic differentiation ( Figure 4D ), although the gene expression levels of mature cholangiocyte markers in these cells did not change (Figure 4E) . The ASGR1-positive cells in the HBC P0-, HBC P10-, and HBC clone-derived population accounted for approximately 60%, 90%, and 90% of the total, respectively ( Figure 4F ). The HBC P0-, HBC P10-, or HBC clone-derived hepatocyte-like cells had the ability to produce ALB (Figure 4G , left) and urea ( Figure 4G, right) . Next, the hESC-derived HBCs were differentiated into cholangiocyte-like cells as described in Figure 4H . After 2 weeks of biliary differentiation, tubular structures (Fig-ure 4I ) that were CK7 positive ( Figure 4J ) were observed. Although the gene expression levels of mature hepatocyte markers ( Figure 4K ) in the HBC P0-, HBC P10-, or HBC clone-derived cholangiocyte-like cells did not change, the gene expression levels of mature cholangiocyte markers ( Figure 4L ) in these cells were higher than those in the cells that had not undergone differentiation. Similar results were obtained by using another hESC line (H1) and hiPSC line (Dotcom) ( Figure S4 ). Moreover, HBC-derived hepatocyte-like cells exhibited CYP metabolism capacity ( Figure S5A ) and a functional urea cycle that could response to ammonia ( Figure S5B ) and were considered to have potential to be applied in the prediction of drug-induced hepatotoxicity ( Figure S5C ). Taken together, these results indicated that the hPSC-derived HBCs have the ability to differentiate into both hepatic and biliary lineages in vitro.
In Vivo Cell Transplantation Assays of the hPSC-Derived HBCs
To examine whether the hESC-derived HBCs could be used for hepatocyte transplantation, these cells were transplanted into CCl 4 -treated immunodeficient mice as shown in Figure 5A . The hepatocyte functionality of the hESCderived HBC P0 or HBC P10 was assessed by measuring secreted human ALB levels in the recipient mice ( Figure 5B ). Although human ALB was detected in the mice that were transplanted with the hESC-derived HBC P0 or HBC P10, it was not detected in the mice that were not transplanted with these cells. The ALB-positive cells were observed in mice transplanted with the hESC-derived HBC P0 or HBC P10 ( Figure 5C ). Most of the ALB-positive cells in mice transplanted with the hESC-derived HBC P10 were AFP negative ( Figure 5D ), indicating that transplanted hESCderived HBCs were differentiated into mature hepatocytelike cells (some of them were binuclear [ Figure 5E , white arrows]). These results demonstrated that hESC-derived HBCs have the potential to be applied for hepatocyte transplantation.
(C) The hESC-derived cells (day 9) were plated onto a human LN111, 211, 411, or 511-coated dish. The percentage of AFP-positive cells was examined by using FACS analysis on day 9 (before passage and after passage [HBC P0]) or day 16. Data represent the mean ± SD from three independent experiments. (D) The hESC-derived cells cultured on a human LN111-coated dish for 7 days were subjected to immunostaining with anti-AFP (green) antibodies. (E) The hESC-derived cells (day 9) were plated onto human LN111, 211, 411, or 511-coated dishes. The gene expression levels of AFP and pan-hepatoblast markers (CD133, EpCAM, CK8, and, CK18) were measured by real-time RT-PCR on day 16. The gene expression levels in the hESC-derived HBCs (the LN111-attached cells were collected at 15 min after plating) were taken as 1.0. (F) The HBCs derived from hESCs (H9) or hiPSCs (Dotcom) were cultured and cell growth was analyzed by obtaining a cell count at each passage. Data represent the mean ± SD from three independent experiments. (G) The percentage of AFP-positive cells was examined by using FACS analysis on day 9 (before passage), P1 (HBCs passaged once), P10 (HBCs passaged ten times), and P15 (HBCs passaged 15 times). Data represent the mean ± SD from seven independent experiments. See also Tables S2 and S3 . 
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DISCUSSION
The main purpose of this study was to establish and characterize expandable HBCs from hPSCs. First, we identified that human LN111 could support self-renewal and proliferation of hPSC-derived HBCs in the presence of HGF and EGF. Second, we showed that the hPSC-derived HBCs have the potential to segregate into both hepatic and biliary lineages, and to integrate into the mouse liver parenchyma. We have demonstrated that the hPSC-derived HBCs could be maintained on a human LN111-coated dish in an integrin a6and b1-dependent manner (Figure 1) . It is known that undifferentiated hPSCs could be maintained on a human LN511-coated dish but not on a human LN111-coated dish (Rodin et al., 2010) . This might suggest that human LN111 has the potential not only to selectively maintain HBCs, but also to eliminate residual undifferentiated cells. Our hepatoblast-like cells could efficiently proliferate for more than 3 months on a human LN111-coated dish (Figure 2 ). In the human liver development (during 5-10 weeks gestation), laminin is observed in both the perisinusoidal space and portal tracts (Couvelard et al., 1998) . The expression of laminin is localized around the periportal biliary trees during the later stage of liver development (Couvelard et al., 1998) . Hepatic stem cells reside around the hepatic portal area (Clément et al., 1988) . It is also known that laminin is accumulated around oval cells although laminin is not expressed around quiescent mature hepatocytes (Paku et al., 2001) . These facts suggest that laminin plays an important role in the maintenance and proliferation of hepatoblasts.
The hPSC-derived HBC P10 and clone were positive for hepatoblast markers (AFP, ALB, CYP3A7, and I-CAM), but negative for hepatic stem cell markers (N-CAM and Claudin 3) ( Figure 3) (Schmelzer et al., 2007) . Although the hPSCderived HBCs were able to expand on human LN111-coated dish, Schmelzer et al. showed that human hepatoblasts do not proliferate under a monolayer culture condition, but human hepatic stem cells could self-replicate for more than 6 months (Schmelzer et al., 2007) . Although further investigations of the hepatoblast characteristics in the hPSC-derived HBCs will be needed in the future, the results in the present study suggest that the characteristics of hPSC-derived HBCs expanded on human LN111-coated dishes were similar to those in human hepatoblasts isolated from the human liver (Schmelzer et al., 2007; Zhang et al., 2008) .
The hPSC-derived HBCs had the ability to integrate into the mouse liver parenchyma (Figure 5) , in the manner of human hepatic stem cells or hepatoblasts (Schmelzer et al., 2007) . The human ALB serum levels (approximately 20-70 ng/ml) in mice transplanted with the hESC-derived HBC P0 or HBC P10 were comparable to those in the previous paper in which the hESC-derived definitive endoderm cells, hepatoblasts, and hepatocyte-like cells were transplanted into mice (Liu et al., 2011) , but were lower than those of human liver chimeric mice (Tateno et al., 2004) . Human ALB serum levels would increase if more suitable host mice, such as urokinase plasminogen activator-SCID mice were used (Tateno et al., 2004) .
In this study, we have developed a technology for the maintenance and proliferation of hPSC-derived HBCs by using human LN111. To transplant these cells for purposes of regenerative medicine, a xeno-free culture condition for hPSC-derived HBCs must be developed in the future. It is hoped that the hPSC-derived HBCs and their derivatives will be helpful in various medical applications, such as drug screening and regenerative medicine.
EXPERIMENTAL PROCEDURES hESC and hiPSC Culture
The hESC lines (H1 [WA01] and H9 [WA09] [WiCell Research Institute]) and the hiPSC line, Dotcom (JCRB number: JCRB1327) Nagata et al., 2009) , were maintained on a feeder layer of mitomycin-C-treated mouse embryonic fibroblasts (Millipore) with ReproStem medium (ReproCELL) supplemented with 5 and 10 ng/ml fibroblast growth factor 2 (FGF2) (Katayama Kagaku Kogyo), respectively. H1 and H9 were used following the Guidelines for Derivation and Utilization of Human Embryonic Stem Cells of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and, furthermore, the study was approved by an independent ethics committee.
In Vitro Hepatoblast Differentiation
The differentiation protocol for the induction of definitive endoderm cells and hepatoblasts was based on our previous report with some modifications Takayama et al., 2012a Takayama et al., , 2012b Takayama et al., , 2013 . In mesendoderm differentiation, hESCs/iPSCs were (C-F) The gene expression levels of hepatic stem cell markers (C), pan-hepatoblast markers (D), hepatoblast markers (E), and mature hepatocyte (CYP3A4, 7A1, 2C9, and TO) or cholangiocyte markers (integrin b4 and SOX9) (F) were measured in the definitive endoderm cells, HBC P0, HBC P1, or HBC P10 by real-time RT-PCR. (G) The gene expression levels of CD13, CK7, DLK1, and PROX1 were measured in the hESC-derived definitive endoderm cells, HBC P0, HBC P1, or HBC P10 by real-time RT-PCR. Data represent the mean ± SD from three independent experiments. Statistical significance was evaluated by ANOVA followed by Bonferroni post hoc tests to compare four groups (DE cells, HBC P0, HBC P1, and HBC P10). Groups that do not share the same letter are significantly different from each other (p < 0.05). DE, definitive endoderm cells. See also Figures S2 and S3 and Tables S2-S4.
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Self-Renewing Human ESC/iPSC-Derived HBCs cultured for 2 days on Matrigel (BD Biosciences) in differentiation hESF-DIF medium that contains 100 ng/ml Activin A (R&D Systems) (hESF-DIF medium was purchased from Cell Science & Technology Institute; differentiation hESF-DIF medium was supplemented with 10 mg/ml human recombinant insulin, 5 mg/ml human apotransferrin, 10 mM 2-mercaptoethanol, 10 mM ethanolamine, 10 mM sodium selenite, and 0.5 mg/ml bovine fatty acid free serum albumin [all from Sigma]). To generate definitive endoderm cells, the mesendoderm cells (day 2) were transduced with 3,000 vector particle (VP)/cell of FOXA2-expressing adenovirus vectors (Ad-FOXA2) for 1.5 hr and cultured until day 6 on Matrigel in differentiation hESF-DIF medium supplemented with 100 ng/ml Activin A. For induction of hepatoblasts, the definitive endoderm cells were cultured for 3 days on a Matrigel in differentiation hESF-DIF medium supplemented with 30 ng/ml bone morphogenetic protein 4 (BMP4) (R&D Systems) and 20 ng/ml FGF4 (R&D Systems).
Establishment and Maintenance of the hPSC-Derived HBCs
The hPSC-derived HBCs were first purified from the hPSC-derived cells (day 9) by selecting attached cells on a human recombinant LN111 (BioLamina)-coated dish at 15 min after plating. The hPSC-derived HBCs were cultured on a human LN111-coated dish (2.0 3 10 4 cells/cm 2 ) in maintenance DMEM/F12 medium (DMEM/F12 medium [Invitrogen] was supplemented with 10% FBS, 1 3 insulin/transferrin/selenium, 10 mM nicotinamide, 10 À7 M dexamethasone (DEX) (Sigma), 20 mM HEPES, 25 mM NaHCO 3 , 2 mM L-glutamine, penicillin/streptomycin, 40 ng/ml hepatocyte growth factor [HGF] [R&D Systems] and 20 ng/ml epidermal growth factors [EGF] [R&D Systems]). The medium was refreshed every day. The hPSC-derived HBCs were dissociated with Accutase (Millipore) into single cells and subcultured every 6 or 7 days.
Establishment and Maintenance of a Single hPSC-Derived HBC
For single-cell culture, the single HBC was plated to separate well of human LN111-coated 96-well plate in maintenance DMEM/F12 medium supplemented with 25 mM Y-27632 (ROCK inhibitor) (Millipore), and then colonies derived from a single cell were manually picked up and cultured as well as HBCs (these cells were designated the HBC clone).
In Vitro Hepatocyte and Cholangiocyte Differentiation
To induce hepatocyte differentiation, the hPSC-derived HBC P0, HBC P10, and HBC clone were cultured for 14 days on a Matrigel-coated dish (7.5 3 10 4 cells/cm 2 ) in HCM (Lonza) supplemented with 20 ng/ml HGF, 20 ng/ml Oncostatin M (OsM) (R&D Systems), and 10 À6 M DEX. To induce cholangiocyte differentiation, the hPSC-derived HBC P0, HBC P10, and HBC clone were cultured in collagen gel for 14 days. To establish collagen gel plates, 500 ml collagen gel solution (consisting of 400 ml type I-A Collagen (Nitta gelatin), 50 ml 10 3 DMEM, and 50 ml of 200 mM HEPES buffer containing 2.2% NaHCO 3 and 0.05 M NaOH) was added to each well, and then the plates were incubated at 37 C for 30 min. The hPSC-derived HBC P0, HBC P10, and HBC clone (5 3 10 4 cells) were resuspended in 500 ml differentiation DMEM/F12 medium (differentiation DMEM/F12 medium was supplemented with 20 mM HEPES, 2 mM L-glutamine, 100 ng/ml EGF, and 40 ng/ml insulin-like growth factor 2 [ILGF2]), and then mixed with 500 ml of the collagen gel solution and plated onto the basal layer of collagen. After 30 min, 2 ml of differentiation DMEM/F12 medium was added to the well.
Ad Vectors
Ad vectors were constructed by an improved in vitro ligation method. The human EF-1a promoter-driven FOXA2-expressing Ad vectors (Ad-FOXA2) were constructed previously (Takayama et al., 2012b) . All of Ad vectors contain a stretch of lysine residue (K7) peptides in the C-terminal region of the fiber knob for more efficient transduction of hESCs, hiPSCs, mesendoderm cells, and definitive endoderm cells, in which transfection efficiency was almost 100%, and purified as described previously (Inamura PH 48 hr were taken as 1.0. In (E), the gene expression levels in HBC P10 (before differentiation) were taken as 1.0. Data represent the mean ± SD from three independent experiments. Student's t test indicated that gene expression levels of the hepatocyte markers in ''after'' were significantly higher than those in ''before'' (p < 0.01). (F) The efficiency of hepatocyte differentiation was measured by estimating the percentage of ASGR1-positive cells using FACS analysis. (G) The amounts of ALB (left) and urea (right) secretion were examined. Data represent the mean ± SD from three independent experiments. Student's t test indicated that the percentage of ASGR1-positive cells, the ALB secretion level, and urea secretion level in ''after'' were significantly higher than those in ''before'' (p < 0.01). (K and L) The gene expression levels of hepatocyte (K) or cholangiocyte (L) markers in the HBC P0-, HBC P10-, or HBC clone-derived cholangiocyte-like cells were measured by real-time RT-PCR after 14 days of cholangiocyte differentiation. In (K), the gene expression levels in PH 48 hr were taken as 1.0. In (L), the gene expression levels in HBC P10 (before cholangiocyte differentiation) were taken as 1.0. Data represent the mean ± SD from three independent experiments. Student's t test indicated that the gene expression levels of cholangiocyte markers in ''after'' were significantly higher than those in ''before'' (p < 0.01). ''Before'' indicates the HBCs before hepatocyte or cholangiocyte differentiation; ''After'' indicates the HBCs after hepatocyte or cholangiocyte differentiation. See also Figures S4 and S5 and Tables S1-S4. Tables S2 and S3 . Takayama et al., 2011; Tashiro et al., 2010) . The VP titer was determined by using a spectrophotometric method.
Flow Cytometry
Single-cell suspensions of the hPSC-derived cells were fixed with 4% paraformaldehyde (PFA) at 4 C for 10 min and then incubated with the primary antibody (described in Table S2 ), followed by the secondary antibody (described in Table S3 ). Control cells were incubated with anti-mouse, goat, or rabbit immunoglobulin (Ig) G antibodies (Santa Cruz Biotechnology) and then incubated with the secondary antibody. Flow cytometry analysis was performed using a fluorescence-activated cell sorting (FACS) LSR Fortessa flow cytometer (BD Biosciences). Cell sorting was performed using a FACS Aria (BD Biosciences).
RNA Isolation and RT-PCR
Total RNA was isolated from hPSCs and their derivatives using ISOGENE (Nippon Gene). cDNA was synthesized using 500 ng of total RNA with a Superscript VILO cDNA synthesis kit (Invitrogen). Real-time RT-PCR was performed with SYBR green PCR Master Mix (Applied Biosystems) using an Applied Biosystems StemOnePlus real-time PCR systems. Relative quantification was performed against a standard curve, and the values were normalized against the input determined for the housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase. The primer sequences used in this study are described in Table S4 . In addition, we confirmed that every beta integrin primer used in this manuscript showed a similar amplification efficacy (Table S5 ). The amplification efficiency was calculated from the slope of the standard curve according to the following formula: e = 10^(À1/slope)-1. Every beta integrin primer used in this manuscript showed a similar amplification efficacy.
Immunohistochemistry
The cells were fixed with 4% PFA for 15 min and then blocked with PBS containing 2% FBS, 2% bovine serum albumin (BSA), and 0.1% Triton X-100 (Wako Pure Chemicals Industries) for 1 hr. The cells were incubated with primary antibody (described in Table  S2 ) at 4 C for overnight, followed by incubation with a secondary antibody (described in Table S3 ) at room temperature for 1 hr. Nuclei were counterstained with DAPI (blue).
ELISA
The hPSC-derived HBC P0, HBC P10, and HBC clone were differentiated into the hepatocyte-like cells as described in Figure 4A . The culture supernatants, which were incubated for 24 hr after fresh medium was added, were collected and analyzed for the amount of ALB secretion by ELISA. ELISA kits for ALB were purchased from Bethyl Laboratories. The amount of ALB secretion was calculated according to each standard followed by normalization to the protein content per well. The human ALB amount in mice serum was also examined by ELISA.
Transplantation of the hESC-Derived HBCs
The hESC-derived HBCs were dissociated using accutase and then suspended with maintenance DMEM/F12 medium without serum.
Eight-to 10-week-old Rag2/IL2Rg double-knockout mice were prepared. The hESC-derived HBCs (1 3 10 6 cells) were transplanted 24 hr after administration of CCl 4 (4 ml/kg) by intrasplenical injection. Recipient mouse liver and blood were harvested at 2 weeks after transplantation. The livers were fixed with 4% PFA and processed for immunohistochemistry. Human hepatocytes producing the ALB, AFP, and aAT protein were identified in mouse liver by an antibody specifically recognizing human but not mouse albumin. In addition, serum was extracted and subjected to ELISA analysis.
All animal experiments were conducted in accordance with institutional guidelines.
Urea Secretion
The hPSC-derived HBC P0, HBC P10, and HBC clone were differentiated into hepatocyte-like cells as described in Figure 4A . The culture supernatants, which were incubated for 24 hr after fresh medium was added, were collected and analyzed for the amount of urea secretion. The urea measurement kits were purchased from BioAssay Systems. The amount of urea secretion was calculated according to each standard followed by normalization to the protein content per well. In Figure S5B , both the HBC-derived hepatocyte-like cells and primary human hepatocytes (PHs) (three lots of cryopreserved human hepatocytes were used), that were cultured for 48 hr after the cells were plated (PH 48 hr), were cultured in HCM (containing glutamine) or DMEM (not containing glutamine; Wako) in the presence or absence of 1 mM ammonium chloride (NH 4 Cl, Wako) for 24 hr, and then the amount of urea secretion was measured.
Primary Human Hepatocytes
Three lots of cryopreserved human hepatocytes (lot Hu8072
[CellzDirect], HC2-14, and HC10-101 [Xenotech]) were used. The vials of hepatocytes were rapidly thawed in a shaking water bath at 37 C; the contents of the vial were emptied into prewarmed Cryopreserved Hepatocyte Recovery Medium (Gibco) and the suspension was centrifuged at 100 g for 10 min at room temperature. The hepatocytes were seeded at 1.25 3 10 5 cells/cm 2 in HCM (Lonza) containing 10% fetal calf serum (FCS) (Gibco) onto type I collagen-coated 12-well plates. The medium was replaced with hepatocyte culture medium containing 10% FCS 6 hr after seeding. The hepatocytes, which were cultured 48 hr after plating the cells, were used in the experiments.
Adhesion-Blocking Assay Using Integrin Antibody
Twelve-well plates were coated with human recombinant LN111, 211, 411, or 511 (all from BioLamina) and blocked by 1% heat-denatured BSA containing PBS. The hESC-derived single cells were incubated with function-blocking antibodies to integrin a6 and b1 (at the concentrations as recommended by the manufacturer) for 30 min, plated on a human LN111-coated 12-well dish, and allowed to adhere for 1 hr at 37 C. After unattached cells were removed, the remaining adherent cells were fixed for 20 min with 5% glutaraldehyde. The hESC-derived cells that had adhered to the wells were stained with 200 ml of 0.3% crystal violet (Wako) solution at room temperature for 15 min. Excess crystal violet was then removed, and the wells were washed three times. Fixed crystal violet was solubilized in 200 ml of 100% ethanol at room Stem Cell Reports j Vol. 1 j 322-335 j October 15, 2013 j ª2013 The Authors 333
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Self-Renewing Human ESC/iPSC-Derived HBCs temperature for 15 min. Cell viability was estimated by measuring the absorbance at 595 nm of each well using a microtiter plate reader (Sunrise, Tecan).
CYP Activity
To measure the CYP1A2, 2C9, and 3A4 activity of the cells, we performed lytic assays by using P450-GloTM CYP1A2, 2C9, and 3A4 Assay Kits (Promega), respectively. We measured the fluorescence activity with a luminometer (Lumat LB 9507; Berthold) according to the manufacturer's instructions. The CYP activity was normalized with the protein content per well.
Karyotyping
This experiment was carried out at Chromosome Science Labo.
Cell Viability Tests
Cell viability was assessed by using a WST-8 assay kit (Dojindo), and the results are presented in Figure S5C . After treatment with test compounds, such as acetaminophen (Wako) and troglitazone (Wako) for 24 hr, the cell viability was measured. The control cells were incubated in the absence of test compounds and were considered to have 100% viability value. Controls were treated with DMSO (final concentration 0.1%).
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